@adamfeuerstein With all due respect, you seem to be overconfident in your judgement of a biotech company. Of course, any pre-commercial biotech co can have up and down regardless of the scientific merit of their IP. Case in point, a few years ago, you trashed Omeros badly. Look them up now.
$qure
Listen to Sarah Tabrizi explaining AMT-130 and how two patients went back to work. Please share and retweet. This was last week at the Samuel Gee lecture.
@BussinBiotech@STL_Biotech Most acute SAH patients end up in ICU, intubated and unconscious. Any clinicians working in ICU understand how difficult to maintain therapeutic level of oral medications through an NG-tube. IV nimodipine makes a lot of sense for clinicians working in this field.
@BussinBiotech@STL_Biotech Nicardipine is not recommended for the prevention of vasospasm in SAH. Prevention of vasospam in SAH needs to walk a fine line between vasodilation and hypotension. Nicardipine tends to tilt it towards hypotension, which could lead to cerebral ischemia.
@anish_koka Here is the reference: https://t.co/SSTBGgRRZE
Tominersen study never reduced CSF nfl level below baseline. The primary reason for ASO failure is due to the fact that HD is primarily a disease of caudate nucleus. ASO may reduce mHTT overall, but not enough in the caudate.
@anish_koka With all due respect, 1) placebo effects can't last for more than 3 years, 2) CSF nfl level is an objective measure of neuronal death, and mean CSF nfl level was reduced by 11% at 24 months while natural history controls showed 26% increase over the same period (p=0.02).
@meremrtl@Benbiotechrese1 I read your SA article. I don't think you understand the dynamics of MS drug prescription very well. Please check with your friends working in a MS clinic or an infusion center. Neurologists will choose a drug that has less side effects, higher efficacy, and better compliance.
Today we report in @ScienceMagazine a one-time base editing treatment for Spinal Muscular Atrophy (SMA), the leading genetic cause of infant mortality worldwide, affecting ~1 in 10,000 births. https://t.co/oLp8VN0Iiw
PDF: https://t.co/JoKm9BxW89
1/17
Generally speaking, men mate socioeconomically horizontally and down, women horizontally and up — placing a higher bar on education, achievement, education & earning potential
@billmaher@RealTimers
.@MarkHertling: “Power equals resources times will.”
Listen to Lt. Gen. Hertling break down the analytical framework for assessing Russian and Ukrainian capabilities in the fight. US support is key to that equation.
BOOM: General Milley destroys Matt Gaetz on our need to understand racism in America. Look at Matt's response. 👇
Is that the response of a racist or just an enormous asshole?
Bravo @harvardmed 'Harvard Medical School and beyond, I write today to announce that HMS will no longer submit data to U.S. News & World Report (USNWR) to support their “best medical schools” survey and rankings.' Dean Daley
@SnackBioTech Considering half of the narsoplimab group didn't get the doses as prespecified and the analysis included those patients, the result seems to indicate a significant mortality benefit.
Interesting data on inhibition of #complementbiology in #Covid_19@clintransmed:
- https://t.co/xdTyM3hX6U
They analyzed longitudinal🩸samples from 9⃣ severely ill #COVID19 patients treated with an anti-MASP-2 monoclonal antibody & 9⃣ untreated controls, all admitted to the ICU.